Overview of Onchocerciasis infection in Nigeria: The way forward Anidi MaryStella, MPH Student Walden University PH6165-4 Environmental Health Instructor: Dr. Raymond Thron 4 TH Term, 2009
Dec 21, 2015
Overview of Onchocerciasis infection in Nigeria: The way
forward
Anidi MaryStella, MPH Student Walden University
PH6165-4 Environmental HealthInstructor: Dr. Raymond Thron
4TH Term, 2009
Objectives• At the end of this presentation, we would have:At the end of this presentation, we would have:
– Increased understanding of onchocerciaisis.
– Increased understanding of the devastating impact of onchocerciasis on rural dwellers in Nigeria.
– Increase our knowledge about best practices and translate such practices into a national strategy for effective prevention and control measures.
– Increase our knowledge about sustainable strategies for controlling the diseases.
Onchocerciasis
• Also known as river blindness• A chronic disease caused by a filarial
nematode Onchocerca volvolus• O. volvolus is transmitted to humans by blood-
sucking blackflies- Simulium damnosum. • O. volvolus infests the eyes and epidermal
tissues of humans with microfilaria.
Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
Overview of onchocerciasis• Blackflies- Simulium damnosum breed only in
well oxygenated river especially fast flowing rivers.
• The larvae requires aquatic life to complete its life cycle.
• Infective larvae gains entrance to humans via exposed wounded skin.
• Larvae moves to subcutaneous tissues where they become encapsulated and form nodules.
World Health Organization. (2009). Onchocerciasis. Retrieved from http://www.who.int/topics/onchocerciasis/en/
Overview of onchocerciasis contd.
• The microfilariae found in the infected humans fluid and blood are transferred to the fly during blood meal.
• The larvae immobilizes the hosts cellular immune response.
• The host immune response to the dead microfilariae results in the formation of nodules.
Onwujekwe, O., Shi, E., Nwagbo, D., Akpala, C., Okonkwo, P. (1998). Willingness to pay for community-based ivermectin distribution: A study of three onchocerciasis-endemic communities in Nigeria. Tropical Medicine and International Health. 3(10):802-808.
Overview – life cycle
Center for Disease Prevention and Control. (2009). Onchocerciasis. Retrieved from http://www.dpd.cdc.gov/dpdx/hTML/ImageLibrary/A-F/Filariasis/body_Filariasis_il20.htm
Epidemiology• According to WHO, (2009) ‘Onchocerciasis is the
world’s second leading infectious cause of blindness’ (WHO, 2009).
• An estimate of 18 million people are infected with Onchocerciasis (Alonso et al, 2009).
• 99% of infected persons live in Africa (Alonso et al, 2009).
Reference1. Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
2. Special Programme for Research & Training in Tropical Diseases (TDR). (2009). Onchocerciasis. Retrieved from http://www.who.int/tdr/svc/diseases/onchocerciasis
Epidemiology• Globally, 270,000 preventable blindness
resulted in this infection (Alonso et al, 2009).• Globally, 500, 000 people are visually impaired
as a result of this infection (Alonso et al, 2009).
• About 40, 000 people become blind annually because of this infection (Alonso et al, 2009).
Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
Epidemiology contd.• Globally, an estimate of 80 million are at risk
(Abanobi, O., Anosike, J., 2000).• Approximately 40 million persons are at risk in
Nigeria (Abanobi, O., Anosike, J., 2000).• Current estimates indicates that 7 million
Nigerians are infected (Abanobi, et al., 2000).• > 120,000 Nigerians are suffering from
onchocerciasis related blindness.Abanobi, O., Anosike, J. (2000). Control of onchocerciasis in Nzerem-Ikem, Nigeria: baseline prevalence and mass distribution of ivermectin. Public Health. 114: 402-406
The figures in Nigeria
• > 1,000,000 adults Nigerians are blind • An estimate of 3,000,000 are visually impaired• Number targeted for therapeutic
onchocerciasis treatment 29, 509, 353 (WHO, 2009).
ReferenceSight saver. (2009). Important new data about blindness in Nigeria. Retrieved from http://www.sightsavers.org/our_work/around_the_world/west_africa/nigeria/9858.html
World Health Organization. (2009). Nigeria. Retrieved from http://www.who.int/apoc/countries/nga/en/
Stratification of national endemicity
• Mesoendemic zones are the savannah zones of the country.– Within the mesoendemic zones some areas have
high disease burden.
• Hyperednemicity zone for Onchocerciasis is within the rain forest zone of the country.– Some areas within this zone have low disease
burden.
Abanobi, O., Anosike, J. (2000). Control of onchocerciasis in Nzerem-Ikem, Nigeria: baseline prevalence and mass distribution of ivermectin. Public Health. 114: 402-406
Climatic map of Nigeria
Climate Map of Nigeria
Climate of map. (2009). Retrieved from http://www.onlinenigeria.com/maps/climateMap.asp
Trend of infection in Nigeria
• The concentration of the infection is highest in rural agricultural communities.
• Rural dwellers flee from this plaque and migrate to urban cities disrupting the socioeconomic development in their communities.
Reference1 Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
2. Abanobi, O., Anosike, J. (2000). Control of onchocerciasis in Nzerem-Ikem, Nigeria: baseline prevalence and mass distribution of ivermectin. Public Health. 114: 402-406
Implication of onchocerciasis infection
• Health– Infects multiple organs. Presence of other co-
infections like malaria, typhoid, and other tropical diseases can be debilitating .
– Psychosocial imbalance.– Psychological trauma– Big burden on the national health system.
• Socioeconomic consequences– Increases the national poverty level.
Impact of onchocerciasis on rural dwellers• Underdevelopment.• Social marginalization.• Sociocultural stigmatization.• Settlement.• Increased mortality of affected people due to negligence and
lack of proper medical care.• Lack of resourceful individuals to advocate for the cause of
the community.• Economic loss
Reference1 Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
2. Abanobi, O., Anosike, J. (2000). Control of onchocerciasis in Nzerem-Ikem, Nigeria: baseline prevalence and mass distribution of ivermectin. Public Health. 114: 402-406
Impact on onchocerciasis on the economy
• The socioeconomic development of fertile lands zones is low thereby affecting the productive of cash crops.
• Gross National Productivity is low.• The cumulative average of the national GDP will be
less than $2 (US dollar).• The poor communities will solely depend on the
average and rich communities for their livelihood and sustenance.
Onwujekwe, O., Shu, E., Nwagbo, D., Akpala, O., Okonkwo, P., (1998). Willingness to pay for community-based ivermectin distribution: A study of three onchocerciasis-endemic communities in Nigeria. Tropical Medicine and International Health 3(10):802- 808
Impact of onchocerciasis on the health system
• The rural health and medical system is in dire need of help.
• The most affected communities are medically underserved.
• They presence of co-infection rapidly depletes the limited allocated funds for treating other related illness.
• This constitutes huge burden of the health system- burden includes cost of treatment, care, and support.
• Healthcare providers are easily overwhelmed by this infection leading to huge gaps in service delivery.
Evidence based practice• Village-level education sessions has been proven to be the best
practice in addressing tropical diseases because of the following:– It empowers villagers with information about disease trend and
transmission.– It reduces the psychosocial stress and stigma associated with
infection.– It enables villagers to be actively involved in prevention measures
thereby minimizing the burden of the disease.
This is important because donor funds allocated for prevention is limited and has no therapeutic funds that will enable people to address the psychological and social effect of infection.
Evidence based practice
• The prophylactic distribution and administration of ivermectin to villagers and communities in endemic areas is one evidence that reduces the burden of the disease.
• Treatment adherence is evidentially achievable through proper village-level education.
Shu, E., Onwujekwe, O., Lokili, P., Okonkwo, P., (2000). A health club for a community school in south-eastern Nigeria: influence on adult perception of onchocerciasis and compliance with community-based ivermectin therapy. Tropical Medicine and International Health . 5(3):222-226.
Evidence based practice
• The use of community-directed treatment with ivermectin (CDTI) adopted to eliminated onchocerciasis as a disease of public health importance in tropical regions have been proven to treat millions of people and avert blindness.
• Evidentially effective use CDTI will be the only profitable approach to eliminate onchocerciasis in Nigeria.
Adeboye, G., Akinsanya, B., Otubanjo, A., Ibidapo, C., Atalabi, T., Okwuzu, J., Adejai, E., Braide, E. (2008). Prevalence of loiasis in Ondo State, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA). Annal sof Tropical Medicine and Parasitology. 102(3):215-227.
Evidence based practice
• Effective interruption of transmission of the parasite requires intermittent repeated treatment for many years with the dose of ivermectin rather than an annual dose.
Emukah, G., Enyinnanya, U., Olaniran, N., Akpan, E., Hopkins, D., Miri, E., Amazigo, U., Okoronkwo, C., Stanley, A., Rakers, L., Richards, F., Katabarwa, M. (2008Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria. Annals of Tropical Medicine and Parasitology. 102(1):45-51.
National treatment coverage
World Health Organization. (2009). Rapid epidemiological mapping of onchocerciasis in Nigeria. Retrieved from http://www.who.int/apoc/countries/ng_web.jpg
Significance of onchocerciasis infection
• The national treatment coverage indicates that most areas are not covered.
• In 2003 it was reported that ivermectin coverage reached its national peak of 70%.
• This rapidly declined in 2004 to 60.7%.• This rapid decline is significantly high and indicates that
coverage needs to be sustained
Adeboye, G., Akinsanya, B., Otubanjo, A., Ibidapo, C., Atalabi, T., Okwuzu, J., Adejai, E., Braide, E. (2008). Prevelance of loiasis in Ondo State, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA). Annal of Tropical Medicine and Parasitology. 102(3):215-227.
Significance of onchocerciasis infection
• The national treatment coverage indicates that most areas are not covered.
• This is significantly important because it gives an insight of the estimated cost required to cover such areas.
• It also indicates the urgency required in reaching the uncovered areas to avoid spread and treatment relapse/resistance.
• This most importantly signifies that government needs to act immediately.
Sustainability of CDTI: the way forward
• The government can provide incentives for communities and CDTI to sustain the activity.
• Incentives helps heals and compensates burn out.• Structure a formal channel of supervision for the
CDTI and support from the health system.• Impact the CDTIs with skills in other public health
areas .• This community development approach will
empower them to be useful resources in addressing other tropical diseases.
Sustainability of CDTI: the way forward
• Empowering the CDTI with a multitiered approach to address other tropical co-infections.
Food for thought
• Collaboratively we can work together to sustain the CDTI initiative.
• The amalgamation of all approaches and our efforts will lead to the elimination of onchocerciasis as a disease of public health importance in Nigeria
Conclusion
• We can make a difference in Nigeria.• Nigeria can be recreated to become a safe
haven for the future generation.• Lets work together to make this happen
Questions
Reference• Abanobi, O., Anosike, J. (2000). Control of onchocerciasis in
Nzerem-Ikem, Nigeria: baseline prevalence and mass distribution of ivermectin. Public Health. 114: 402-406.
• Adeboye, G., Akinsanya, B., Otubanjo, A., Ibidapo, C., Atalabi, T., Okwuzu, J., Adejai, E., Braide, E. (2008). Prevelance of loiasis in Ondo State, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA). Annals of Tropical Medicine and Parasitology. 102(3):215-227.
• Alonso, L., Murdoch, M., Jefre-Bonet. (2009). Psycho-social economic evaluation of onchocerciasis: a literature review. Social medicine. 4(1)8-31.
Reference• Emukah, G., Enyinnanya, U., Olaniran, N., Akpan, E., Hopkins, D.,
Miri, E., Amazigo, U., Okoronkwo, C., Stanley, A., Rakers, L., Richards, F., Katabarwa, M. (2008Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria. Annals of Tropical Medicine and Parasitology. 102(1):45-51.
• Center for Disease Prevention and Control. (2009). Onchocerciasis. Retrieved from
http://www.dpd.cdc.gov/dpdx/hTML/ImageLibrary/A-F/Filariasis/body_Filariasis_il20.htm
.
Reference• Onwujekwe, O., Shu E., Nwagbo, D., Akpala, C., Okonkwo,
P. (1998). Willingness to pay for community-based ivermectin distribution: A study of three onchocerciasis-endemic communities in Nigeria. Tropical Medicine and International Health. 3(10):802-808
• Shu, E., Onwujekwe, O., Lokili, P., Okonkwo, P., (2000). A health club for a community school in south-eastern Nigeria: influence on adult perception of onchocerciasis and compliance with community-based ivermectin therapy. Tropical Medicine and International Health . 5(3):222-226.
Reference
• Special Programme for Research & Training in Tropical Diseases (TDR). (2009). Onchocerciasis. Retrieved from http://www.who.int/tdr/svc/diseases/onchocerciasis.
• World Health Organization. (2009). Onchocerciasis. Retrieved from http://www.who.int/topics/onchocerciasis/en/
• World Health Organization. (2009). Rapid epidemiological mapping of onchocerciasis in Nigeria. Retrieved from http://www.who.int/apoc/countries/ng_web.jpg